BioSpace News Archive

The employees received, in the aggregate, options to purchase 92,793 shares of Sarepta’s common stock.

ClearFlow announced that the cover of the January 2018 issue of The Annals of Thoracic Surgery features a review article that elucidates the biological mechanisms by which retained shed mediastinal blood can trigger postoperative atrial fibrillation (POAF) in susceptible individuals as well as how this could represent a new target for prevention of POAF.

Revance announced presentation of clinical data from the company’s two pivotal SAKURA Phase 3 trials of DaxibotulinumtoxinA Injectable (RT002) at the 20th annual IMCAS (International Master Course on Aging Skin) World Congress, taking place at Palais des Congrès, Paris, France, February 1-3, 2018.

Anika Therapeutics today announced an agreement with the Institute of Integrative Biology at the University of Liverpool to collaborate on research to develop an injectable mesenchymal stem cell (MSC) therapy for the treatment of osteoarthritis (OA).

Mr. Johnson brings to AVEO over three decades of experience in the biotechnology and pharmaceuticals industries, having held commercial and executive management roles at leading global corporations that have a focus on oncology, including Johnson & Johnson, Eli Lilly & Company, ImClone Systems, Dendreon and Pfizer.

Leading immunoassay development and manufacturing specialist BBI Solutions has marked a successful first year since the launch of the landmark Morffi signal enhancement technology.

Navidea announced today that it will hold an online Question & Answer (Q&A) Session with Jed Latkin, Chief Financial and Operating Officer, and Fred Cope, Ph.D., Chief Scientific Officer of Navidea, on Tuesday February 13, 2018 at 5:00 p.m. Eastern Time.

Actinium Pharma announced today that its abstract has been accepted for a poster presentation at the 2018 American Association for Cancer Research Annual Meeting being held April 14-18, 2018 in Chicago, Illinois.